Sec Form 13G Filing - ESOPUS CREEK VALUE SERIES FUND LP - SERIES A filing for SIGA TECHNOLOGIES INC (SIGA) - 2020-01-02

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C.  20549

SCHEDULE 13G

(RULE 13d - 102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b)

(Amendment No. 2)*

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

[ ]            Rule 13d-1(b)

[x]            Rule 13d-1(c)

[ ]            Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

The beneficial ownership of the Reporting Persons (as defined below) as of December 31, 2019.

SIGA Technologies, Inc.  (“Issuer”)

27 East 62^nd Street, New York, New York 10065

The names of the persons filing this statement on Schedule 13G (collectively, the “Reporting Persons”) are:

The principal business address for each of the Reporting Persons is 1325 Avenue of the Americas, Suite 2724, New York, New York 10019.

Esopus Creek Value Series Fund LP – Series A is a Delaware limited partnership. Rainy Daze LLC is a Delaware limited liability company.  Esopus Creek Management LLC is a Delaware limited liability company. Andrew L. Sole is a citizen of the United States.

Common stock, par value $0.0001 per share (the “Common Stock”)

826917106

	(a)	[ ]	Broker or dealer registered under Section 15 of the Exchange Act.
	(b)	[ ]	Bank as defined in Section 3(a)(6) of the Exchange Act.
	(c)	[ ]	Insurance company defined in Section 3(a)(19) of the Exchange Act.
	(d)	[ ]	Investment company registered under Section 8 of the Investment Company Act.
	(e)	[ ]	Investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).
	(f)	[ ]	Employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F).

	(g)	[ ]	Parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G).
	(h)	[ ]	Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act.
	(i)	[ ]	Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;
	(j)	[ ]	Non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J).
	(k)	[ ]	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).  If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____

As of December 31, 2019, Esopus Creek Value Series Fund LP – Series A beneficially owned 3,468,909 shares of Common Stock.

Rainy Daze LLC beneficially owned 610,200  shares of Common Stock.

Esopus Creek Management LLC, as an investment manager of Rainy Daze LLC, may be deemed to have beneficially owned the 610,200  shares of Common Stock beneficially owned by Rainy Daze LLC.

Andrew L. Sole, as the principal of Esopus Creek Advisors LLC, the General Partner of Esopus Creek Value Series Fund LP – Series A, and as the principal of Esopus Creek Management LLC, an investment manager of Rainy Daze LLC, may be deemed to have beneficially owned the 4,079,109 shares of Common Stock beneficially owned by Esopus Creek Value Series Fund LP – Series A and Rainy Daze LLC, and an additional 145,337 shares of Common Stock that he personally owns.

The aggregate percentage of Common Stock reported owned by each person named herein is based upon 81,074,280 shares of Common Stock outstanding as of November 1, 2019, which is the total number of shares of Common Stock outstanding as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 5, 2019.  As of the close of business on December 31, 2019,

(i)            Sole power to vote or to direct the vote of Common Stock:

See Cover Pages Items 5-9.

(ii)            Shared power to vote or to direct the vote of Common Stock:

See Cover Pages Items 5-9.

(iii)            Sole power to dispose or to direct the disposition of Common Stock:

See Cover Pages Items 5-9.

(iv)            Shared power to dispose or to direct the disposition of Common Stock:

See Cover Pages Items 5-9.

If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following [   ].

Not applicable.

Not applicable.

See Exhibit A.

Not applicable.

By signing below the undersigned certifies that, to the best of its or his knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURES

After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct.

Dated:  December 31, 2019

*The Reporting Persons disclaim beneficial ownership in the shares of Common Stock reported herein except to the extent of their pecuniary interest therein.

The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative.  If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference.  The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

Note.  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See s.240.13d-7 for other parties for whom copies are to be sent.

Attention.  Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).

EXHIBIT A

JOINT FILING AGREEMENT

The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock of SIGA Technologies, Inc. dated as of December 31. 2019 is, and any further amendments thereto signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(2) under the Securities Exchange Act of 1934, as amended.

Dated:  December 31, 2019